Health ❯ Healthcare ❯ Medical Research ❯ Oncology

Prostate Cancer

Study Links PSMA PET/CT to 5-Year Outcomes, Informing Salvage Treatment After Prostatectomy

Authors frame the retrospective UCLA data as practice-informing evidence that warrants prospective validation.

Final EMBARK Results Show 40% Lower Mortality With Enzalutamide Plus Leuprolide in High-Risk Recurrent Prostate Cancer

PROX1 gene drives aggressive, treatment-resistant prostate cancer